1994
DOI: 10.1073/pnas.91.5.1716
|View full text |Cite
|
Sign up to set email alerts
|

The role of charge and multiple faces of the CD8alpha/alpha homodimer in binding to major histocompatibility complex class Imolecules: support for a bivalent model.

Abstract: The CD8 dimer interacts with the a3 domain of major histocompatibility complex class I molecules through two immunoglobulin variable-like domains. In this study a crystal structure-informed mutational analysis has been performed to identify amino acids in the CD8a/a homodimer that are likely to be involved in binding to Recently the crystal structure of a soluble form of the human CD8a/a homodimer was solved (12). In the N-terminal domain of each polypeptide, two sheets consisting of five and four antiparall… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
32
0

Year Published

1994
1994
2007
2007

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(34 citation statements)
references
References 38 publications
2
32
0
Order By: Relevance
“…Eighteen to 24 h before transfection, cells were plated out at 2 ϫ 10 5 cells per 60-mm plate. Liposome-mediated transfection was performed, as previously described (13). For expression of the CD8␣␣ homodimer, 4 g of wild-type (WT) or mutant CD8␣ cDNA in 200 l of Optimem was added to 200 l of Optimem plus 16 l of Lipofectamine (both Life Technologies, Grand Island, NY).…”
Section: Cd8 Expression On Cos-7 Cellsmentioning
confidence: 99%
“…Eighteen to 24 h before transfection, cells were plated out at 2 ϫ 10 5 cells per 60-mm plate. Liposome-mediated transfection was performed, as previously described (13). For expression of the CD8␣␣ homodimer, 4 g of wild-type (WT) or mutant CD8␣ cDNA in 200 l of Optimem was added to 200 l of Optimem plus 16 l of Lipofectamine (both Life Technologies, Grand Island, NY).…”
Section: Cd8 Expression On Cos-7 Cellsmentioning
confidence: 99%
“…Human B cell hybridoma were prepared by fusion of EBV-transformed lymphoblasts with the hygromycin B-resistant, hypoxanthine guanine phosphoribosyl transferase (HGPRT) -deficient human myeloma cell line, UC-LUC (22). UC-LUC cells (2 x 107 cells) and EBV-transformed lymphoblasts (4 x I07 cells) were washed twice with serum-free RPMI 1640, and mixed in 50 ml conical tubes.…”
Section: Introductionmentioning
confidence: 99%
“…A secondary binding site, implicated in coreceptor CD8 engagement, is supplied by a conserved region of the ␣2 domain, the ␣3 domain, and ␤ 2 m (26 -31). Specific influence of m-␤ 2 m on CD8 binding to MHC-I has not been established, although cocrystal studies (19,26), mutational analyses (27)(28)(29), and MHC-I tetramer-binding studies (30,31) suggest that alterations in ␤ 2 m could potentially affect the overall association. Importantly, residues glutamine (Q) 6, threonine (T) 28, Q29, and lysine (K) 58 of m-␤ 2 m have been shown to contact directly with CD8␣ through a series of hydrogen bonds and salt bridges (26).…”
mentioning
confidence: 99%